Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Other Working Capital Changes: 2010-2024

Historic Other Working Capital Changes for EyePoint Pharmaceuticals (EYPT) over the last 15 years, with Dec 2024 value amounting to -$30.6 million.

  • EyePoint Pharmaceuticals' Other Working Capital Changes fell 102.80% to -$15,000 in Q4 2019 from the same period last year, while for Dec 2019 it was -$15,000, marking a year-over-year decrease of 105.77%. This contributed to the annual value of -$30.6 million for FY2024, which is 168.83% down from last year.
  • As of FY2024, EyePoint Pharmaceuticals' Other Working Capital Changes stood at -$30.6 million, which was down 168.83% from $44.5 million recorded in FY2023.
  • EyePoint Pharmaceuticals' Other Working Capital Changes' 5-year high stood at $44.5 million during FY2023, with a 5-year trough of -$30.6 million in FY2024.
  • Its 3-year average for Other Working Capital Changes is $4.3 million, with a median of -$868,000 in 2022.
  • Per our database at Business Quant, EyePoint Pharmaceuticals' Other Working Capital Changes spiked by 110,406.67% in 2020 and then crashed by 168.83% in 2024.
  • Over the past 5 years, EyePoint Pharmaceuticals' Other Working Capital Changes (Yearly) stood at $16.5 million in 2020, then tumbled by 105.63% to -$931,000 in 2021, then rose by 6.77% to -$868,000 in 2022, then skyrocketed by 5,229.38% to $44.5 million in 2023, then tumbled by 168.83% to -$30.6 million in 2024.